Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- APPH.F
- Price
- 10.55
- Stock movement up
- +0.20 (1.93%)
- Company name
- APONTIS PHARM. AG INH ON
- Exchange
- (F ,
- Currency
- EUR )
- Sector
- Healthcare >Drug Manufacturers - Specialty & Generic
- Market cap
- 87.88M
- Ent value
- -
- Price/Sales
- -
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- 14.65
- PEG
- -
- EPS growth
- -
- 1 year return
- 24.70%
- 3 year return
- -2.83%
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-08-27
DIVIDENDS
APPH.F does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | - |
| EV to Sales | - |
FINANCIALS
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 10.80 |
| Daily high | 10.80 |
| Daily low | 10.55 |
| Daily Volume | 0K |
| All-time high | 26.30 |
| 1y analyst estimate | 10.00 |
| Beta | 1.18 |
| EPS (TTM) | - |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| APPH.F | S&P500 | |
| Current price drop from All-time high | -59.89% | -3.04% |
| Highest price drop | -89.28% | -56.47% |
| Date of highest drop | 8 Nov 2023 | 9 Mar 2009 |
| Avg drop from high | -56.96% | -11.04% |
| Avg time to new high | 58 days | 12 days |
| Max time to new high | 951 days | 1805 days |
COMPANY DETAILS
Marketcap
87.88M
Marketcap category
Small-cap
Description
Apontis Pharma AG engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany. It offers single pills and other pharmaceutical products with a focus on cardiovascular diseases, such as hypertension, hyperlipidemia, and secondary prophylaxis, as well as respiratory diseases and diabetes. The company was founded in 1946 and is based in Monheim am Rhein, Germany. As of November 21, 2024, Apontis Pharma AG operates as a subsidiary of Zentiva AG.
Employees
137
Website
Investor relations
-
SEC filings
CEO
Country
Germany
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
MONHEIM AM RHEIN, Germany - August 20, 2025 (NEWMEDIAWIRE) - Bruno Wohlschlegel, CEO of APONTIS PHARMA AG (ticker APPH / ISIN DE000A3CMGM5), a leading pharmaceutical company for single-pill combinatio...
August 20, 2025